Previous 10 | Next 10 |
2024-03-07 10:30:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for LEGN on March 7, 2024 10:00AM ET. The previous analyst recommendation was Underperform. LEGN was trading at $63.385 at issue of the analyst recommendation. The overall analyst consensus : B...
2024-02-25 05:00:00 ET Summary AlphaGen Therapeutics and ArtBio, two targeted RLT companies, forged a far-reaching agreement to expand ArtBio’s market and develop new RLTs. Biocytogen Pharma signed an antibody evaluation/option agreement with Gilead Sciences, granting acces...
2024-02-23 13:22:45 ET Legend Biotech ( NASDAQ: LEGN ) shares gained over 6% on Friday after an expert panel of the EU drug regulator, the European Medicines Agency (EMA), adopted a positive opinion for the label expansion of Carvykti (ciltacabtagene autoleucel) to include adult...
2024-02-23 09:58:33 ET Johnson & Johnson's ( NYSE: JNJ ) Janssen Pharmaceutical unit announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its CAR-T cell therapy Carvykti to expand its label for multiple myeloma.... R...
CARVYKTI ® is the first CAR-T therapy for patients with relapsed and refractory multiple myeloma to receive a positive CHMP opinion for second line treatment Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the Commi...
2024-02-18 03:05:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During Q4 2023, Baron Opportunity Fund rose 15.10% (inst.) and for the full-year 2023,...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing, and commercializing novel therapies to treat life-threatening diseases, will host a conference call for investors at 8:00 am ET on Monday, March 11, 2024, to review fourth-quarter...
2024-02-07 11:28:54 ET More on I-Mab Biopharma Seeking Alpha’s Quant Rating on I-Mab Biopharma Historical earnings data for I-Mab Biopharma Financial information for I-Mab Biopharma Read the full article on Seeking Alpha For further details see...
2024-01-29 13:47:30 ET Summary Today, we take a look at Legend Biotech Corporation, a commercial-stage biopharmaceutical company focused on developing cell therapies for oncology and other indications. The company has one approved product on the market, LCAR-B38M, for the treatmen...
2024-01-23 09:47:13 ET Bank of Montreal (FNGD) FNGD is trading DOWN for the last 4 days, and it at trading at $5.17 with volume of 1,660,669 and a one day change of $-0.07 (-1.34%). Bank of Montreal has a 52-week low of 5.10 and a 52-week high of $42.58. The business's 50-day moving...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...